Based on observations that tumors require evasion of cell death, and that Bcl-2 family anti-apoptotic proteins are frequently overexpression or hyper-activated in cancers, it is likely that certain cancers maybe particularly sensitive to targeted inhibition of anti-apoptotic Bcl-2 proteins. Here, BCL2 is linked to cancer.